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During synthesis and export of protein, the majority of the human immunodeficiency virus type 1 (HIV-1)
Env glycoprotein gp160 is retained in the endoplasmic reticulum (ER) and subsequently ubiquitinated and
degraded by proteasomes. Only a small fraction of gp160 appears to be correctly folded and processed and is
transported to the cell surface, which makes it difficult to identify negative sequence elements regulating
steady-state surface expression of Env at the post-ER level. Moreover, poorly localized mRNA retention
sequences inhibiting the nucleocytoplasmic transport of viral transcripts interfere with the identification of
these sequence elements. Using two heterologous systems with CD4 or immunoglobulin extracellular/trans-
membrane domains in combination with the gp160 cytoplasmic domain, we were able to identify two mem-
brane-distal, neighboring motifs, is1 (amino acids 750 to 763) and is2 (amino acids 764 to 785), which inhibited
surface expression and induced Golgi localization of the chimeric proteins. To prove that these two elements
act similarly in the homologous context of the Env glycoprotein, we generated a synthetic gp160 gene with
synonymous codons, the transcripts of which are not retained within the nucleus. In accordance with the
results in heterologous systems, an internal deletion of both elements considerably increased surface expres-
sion of gp160.
The human immunodeficiency virus type 1 (HIV-1) glyco-
protein gp160 is processed into the transmembrane subunit
(TM) gp41 and the nonconvalently linked gp120 glycoprotein,
which binds to the CD4 receptor and chemokine coreceptor
molecules. Cleavage mediated by a cellular furin protease dur-
ing the protein transport through the cis or medial Golgi ap-
pears to be mandatory for membrane fusion (18, 29, 42, 57,
66). Nascent gp160 molecules are bound to GRP78-BiP, cal-
nexin, and calreticulin chaperones and are highly glycosylated,
sulfated, and palmitoylated (5, 18, 24, 36, 49, 71). Correct
folding, as well as glycosylation and oligomerization, was found
to be necessary for efficient protein transport (6, 14, 17, 18, 24,
30, 35, 48, 50). Previous studies demonstrated that the majority
of the Env glycoprotein is intracellularly retained and remains
endoglycosidase H (Endo H) sensitive (31, 32, 53, 69). Only a
minor fraction leaves the endoplasmic reticulum (ER) and is
transported to the cell surface. Recently we showed that the
ER-retained Env glycoprotein is ubiquitinated and degraded
by the proteasome (9; A. Bu¨ltmann and J. Haas, unpublished
data). Glycoprotein surface expression, however, not only de-
pends on ER-mediated quality control and the retention of
misfolded or disassembled Env in the ER but also involves
subsequent steps, including Golgi export and internalization of
surface-expressed Env (58). A tyrosine-based, membrane-
proximal YXXF motif (amino acids [aa] 713 to 716) in the
cytoplasmic gp41 domain was previously reported to be re-
sponsible for endocytosis, but additional, more distal elements
were expected (4, 58).
There are several lines of evidence suggesting that the cyto-
plasmic domain of the TM glycoprotein modulates surface
expression. Deletion of the carboxy terminus, which has been
observed after long-term culture of chronically HIV-1-infected
cells, increases both protein transport and processing of gp160
but leads to a decreased incorporation of glycoproteins into
virions, probably because of a direct interaction between Env
and viral matrix proteins (13, 15, 18, 22, 25, 28, 39, 72, 73).
Moreover, deletion of the cytoplasmic domain appears to re-
duce infectivity of virions due to postentry events (26, 72).
Similar to the case with HIV-1, protein synthesis and process-
ing of the TM protein in simian immunodeficiency virus (SIV)
is modulated by the cytoplasmic domain. Most SIVs isolated by
culturing in human cells possess a premature stop codon trun-
cating the cytoplasmic tail of gp41 (10, 67; V. M. Hirsch, P.
Edmondson, C. M. Murphey, B. Arbeille, P. R. Johnson, and
J. I. Mullins, Letter, Nature 341:573–574, 1989). This trunca-
tion of the cytoplasmic domain of gp160 increases surface
expression, fusogenicity, and, in contrast to the case with
HIV-1, infectivity (10, 54, 63, 64, 74). Regarding HIV-2, which
is highly related to SIV, similar observations have been made
(43).
In HIV-1 infection, unspliced and singly spliced viral mRNA
is not transported into the cytoplasm unless the posttranscrip-
tional regulator Rev is present (21, 23, 38). This nuclear re-
tention of HIV-1 mRNA is caused by multiple poorly localized
negative sequence elements present throughout the viral ge-
nome (2, 7, 12, 21, 45, 56, 60, 61). In the env gene, inhibitory
sequence elements were found in the region containing the
* Corresponding author. Mailing address: Max von Pettenkofer-
Institut, Genzentrum, LMU Mu¨nchen, Feodor-Lynen-Str. 25, 81377
Munich, Germany. Phone: 49 89 2180 6852. Fax: 49 89 2180 6899.
E-mail: haas@lmb.uni-muenchen.de.
5263
5264 BU¨LTMANN ET AL. J. VIROL.
Rev-responsive element, but also in other regions, including
both gp120 and gp41 (7, 21, 45, 56). Thus, sequences suppress-
ing the nucleocytoplasmic mRNA transport colocalize with
peptide motifs acting at the protein level and make it difficult
to dissect both phenomenons.
To identify sequence elements influencing the steady-state
surface expression of Env, we used two different approaches.
First, we investigated the gp41 cytoplasmic domain in two
heterologous systems using chimeras with CD4 and immuno-
globulin extracellular/transmembrane domains, thus rendering
the protein independent of the complex folding and processing
which causes ER retention and degradation of the majority of
the Env glycoprotein. Second, we investigated the sequence
elements identified with the first approach using a synthetic env
sequence with synonymous codons, which proved to be refrac-
tory to mRNA retention. We identified two membrane-distal
sequence elements which suppress Env surface expression and
cause Golgi localization. Deletion of the two elements led to a
significant increase in surface expression of the chimeric re-
porter constructs and of the homologous Env glycoprotein.
MATERIAL AND METHODS
Cell culture and transfection. 293T, an adenovirus transformed human kidney
cell line, and HeLa cervix carcinoma cells were maintained in Dulbecco modified
Eagle medium supplemented with 10% (vol/vol) heat-inactivated fetal calf serum
and 100 IU of penicillin/ml, 100 mg of streptomycin/ml, and 2 mM L-glutamine.
For RNA analysis, 293T cells were transfected by calcium phosphate coprecipi-
tation according to standard protocols. For intracellular localization experi-
ments, HeLa cells were transfected by microinjection.
Plasmid constructs. To generate an MluI restriction site 39 of the transmem-
brane region, human CD4 was amplified by PCR using a cDNA clone as a
template and subsequently cloned into HindIII and NotI restriction sites of
vector pCR3. Similarly, the extracellular domain of human immunoglobulin G1
(IgG1) hooked up to the CD7 transmembrane region followed by an MluI
restriction site was cloned into the HindIII and NotI restriction sites of plasmid
pRK (33). The gp41 cytoplasmic domain and mutants thereof were generated by
PCR amplification using the synthetic gp160 sequence as a template to avoid
nuclear mRNA retention. After the PCR, they were cloned into the MluI and
NotI sites of both the CD4 and the surface immunoglobulin constructs. The
syngp160 mutant constructs were generated by PCR using an EspI site in the
transmembrane region and a NotI site in the 59 untranslated region. For gener-
ation of stably transfected cell lines, the syngp160 constructs were subcloned in
the plasmid pBRep. The HIV-1 gag construct contained a Rev-independently
expressed, synthetic, codon-optimized gag sequence (MN isolate) cloned in
pND14. All constructs were confirmed by sequencing. The following oligonucle-
otides were used for PCR amplification: CD4 for, CGCGGGAAGCTTGCCG
CCACCATGAACCGGGGAGTCCC; CD4 rev, CGCGGGGCGGCCGCTTA
AATGGGGCTACATGTCTTC; CD4Dcyt MluI rev, CGCGGGGCGGCCGCT
TATTACCTTCGGTGCCGGCAACGCGTACAGAAGAAGATGCC; CD4gp41
MluI for, CGCGGGACGCGTGTGCGCCAGGGCTAC; cdm7 rev, CCACAG
AAGTAAGGTTCC; gp41D833 rev, CGCGGGGCGGCCGCTTATTAGAGC
ACCTCGATCACGC; gp41D805 rev, CGCGGGGCGGCCGCTTATTACTGG
CTCCAATACTGGAG; gp41D785 rev, CGCGGGGCGGCCGCTTATTATAG
GAGTTCCACGATGCG; gp41D763 rev, CGCGGGGCGGCCGCTTATTAGC
TGCGGAGGTCGAC; gp41D749 rev, CGCGGGGCGGCCGCTTATTACCT
GCCGCTG; gp41D738 rev, CGCGGGGCGGCCGCTTATTAGCCCTCCTCC
TCGATGC; gp41D728 rev, CGCGGGGCGGCCGCTTATTAGGGCCCGCG
CGGCAC; CD4gp41:749 for, CGCGGGACGCGTCTCGTGCACGGCTTCCT
GG; gp41D768 rev, CGCGGGGCGGCCGCTTATTAGCTGAACAGGAACA
GGC; CD4gp41:750–763 for, CGCGTGTGCACGGCTTCCTGGCGATCATC
TGGGTCGACCTCCGCAGCTAATAAGC; CD4gp41:750–763 rev, GGCCGC
TTATTAGCTGCGGAGGTCGACCCAGATGATCGCCAGGAAGCCGTGC
ACA; CD4gp41:763–785 for, CGCGGGACGCGTCTGTTCCTGTTCAGCTA
CCACCACCGCGACCTGCTGCTGATCGCC; CD4gp41:763–785 rev, CGCG
GGGCGGCCGCTTATTATAGGAGTTCCACGATGCGGGCGGCGATCA
GCAGCAGGTCGCG; gp41Dis1 for, GAACAGGAACAGGAGCCTGCCGC
TGGTGTCG; gp41Dis1 rev, GCGGCAGGCTCCTGTTCCTGTTCAGCTAC;
gp41Dis112 for, GCGGCAGGGGCCGCCGCGGCTGGG; gp41Dis112 rev,
CCCAGCCGCGGCGGCCCCTGCCGCTGGTGTCGC; gp41Dis12 for, GACC
TCCGCAGCGGCCGCCGCGGCTGG; gp41IDis2 rev, CCCAGCCGCGGCG
GCCGCTGCGGAGGTCGA; gp41L776/7A for, CTGGCCGCCATCGCCGCC
CGCATCGTG; gp41L776/7A rev, CCACGATGCGGGCGGCGATGGCGGC
CAGGTCGCGGTGGTGGTAGC; gp41L784/5A for, GAAGCCGCCGGCCG
CCGCGGCTGG; gp41L784/5A rev, CCCAGCCGCGGCGGCCGGCGGCTT
CCACGATGCGGGCGGCG; gp41L776/7/784/5A for, GCCGCCATCGCCGC
CCGCATCGTGGAAGCCGCCGGCCGCCGCGGCTGGG; gp41L776/7/784/5A
rev, GGCGGCTTCCACGATGCGGGCGGCGATGGCGGCCAGGTCGCG
GTGGTGGTAGC; syngp160Dcyt for, TGAGCATCGTGAACCGCTAGC;
syngp160Dcyt rev, GGCCGCTAGCGGTTCACGATGC; gp41 EspI for, CGCG
GGGCTGAGCATCGTGAACCGCGTGCGCCAGGGCTA; pCR3 rev, ATTT
AGGTGACACTATAG; b-actin for, CGCGGGGAATTCAGCTGTGCTACG
TCGC; b-actin rev, CGCGGGGGATCCTCGTGGATGCCACAGG; syngp160
for, GTGCTGAAGTACTGGTGG; wtgp160 for, ATTGGTGGAATCTCCT
AC; pcdm7 rev, CCACAGAAGTAAGGTTCC.
Generation of a synthetic gp160 sequence. The synthetic gp160 sequence was
generated by 15 oligonucleotides used as templates for PCR as described pre-
viously (27). PCR primers of adjacent fragments were overlapping with primers
and included unique restrictions sites at the 59 end. PCR products were either
used for overlapping PCR with adjacent fragments or directly cloned after
phenol extraction, precipitation, and restriction. Subfragments of gp120 and
gp41 were cloned into modified pCdm7 and pUC plasmids containing NheI/PstI/
MluI/EcoRI/BamHI/NotI and BamHI/DraIII/KpnI/EarI/EspI/SalI/BstXI/NotI
polylinkers, respectively. Subsequently, both fragments were added together
using a short oligonucleotide adapter. Finally, the synthetic gp160 sequence was
subcloned into a pCDM7-derived plasmid under the control of a human cyto-
megalovirus immediate-early promotor and a CD5 signal peptide (62). The
correct gp160 sequence was confirmed by double-stranded DNA sequencing.
RNA isolation and cDNA synthesis. Transfected 293T cells were harvested,
washed with cold phosphate-buffered saline (PBS), and lysed with 2 ml of lysis
buffer (10 mM Tris-HCl [pH 7.5], 5 mM MgCl2, 10 mM NaCl, 0.5% NP-40) for
5 min on ice. Subsequently, nuclei and cytoplasms were separated by centrifu-
gation at 3,000 3 g for 10 min at 4°C, 8 ml of 4 M guanidine thiocyanate solution
(4 M guanidine thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% lauryl sarcosyl,
0.7% b-mercaptoethanol) was added to the nuclear fraction, and 6 ml of 6 M
guanidine thiocyanate solution (6 M guanidine thiocyanate, 37.5 mM sodium
citrate [pH 7.0], 0.75% lauryl sarcosyl, 0.7% b-mercaptoethanol) was added to
the cytoplasmic fraction. After shearing of the genomic DNA, 5.7 M CsCl was
overlayed with the guanidine thiocyanate solution in ultracentrifugation tubes.
Centrifugation was performed in an SW40 rotor at 35,000 rpm for 18 h at 20°C.
The RNA pellet was dissolved in diethyl pyrocarbonate (DEPC)-treated H2O,
phenol-chloroform extracted once, and ethanol precipitated.
Prior to cDNA synthesis, the RNA was treated with RQ1 RNase-free DNase
(Promega, Madison, Wis.) for 30 min at 37°C. After inactivation of the DNase by
incubation at 65°C for 10 min, 2 mg of RNA was heat denaturated, and 2 ml
10-fold reverse transcriptase (RT) buffer, 1 ml of deoxynucleoside triphosphate
(25 mM each), 1 ml of RNasin (Roche, Mannheim, Germany), 1 ml of oligo(dT)
primer (250 ng/ml), 1 ml of Moloney murine leukemia virus reverse transcriptase
(New England Biolabs, Beverly, Mass.), and H2O was added to a final volume of
20 ml. After incubation at 37°C for 90 min, the reaction was stopped by heat
inactivation at 67°C for 15 min.
Southern blot analysis. After electrophoresis, the agarose gel was incubated in
denaturation solution (0.5 M NaOH, 1.5 M NaCl) for 30 min, rinsed with H2O,
and submerged in neutralization solution (0.5 M Tris-HCl [pH 7.5], 3 M NaCl)
FIG. 1. The peptide motif is1 in the cytoplasmic gp41 domain is responsible for suppressed surface expression and Golgi localization. (a)
Schematic diagram of the chimeric constructs with the CD4 extracellular/transmembrane and gp41 cytoplasmic domains used to identify the
retention elements. (b) HeLa cells were microinjected with the constructs indicated in panel a, stained with the CD4-specific monoclonal antibody
Q4120 and a FITC-conjugated secondary antibody, and subsequently analyzed by confocal laser scanning microscopy. The cross-section levels are
indicated by white bars. The cells shown are representative of all cells microinjected with the respective constructs. Similar results were obtained
in at least three independent experiments.
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FIG. 2. A second peptide motif, is2, in the cytoplasmic gp41 domain is necessary for suppressed surface expression and Golgi localization. (a)
Schematic diagram of the chimeric constructs with the CD4 extracellular/transmembrane and gp41 cytoplasmic domains used to identify the
retention elements. (b) HeLa cells were microinjected with the constructs indicated in panel a, stained with the CD4-specific monoclonal antibody
Q4120 and a FITC-conjugated secondary antibody, and subsequently analyzed by confocal laser scanning microscopy. The cross-section levels are
indicated by white bars. The cells shown are representative of all cells microinjected with the respective constructs. Similar results were obtained
in at least three independent experiments.
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FIG. 3. Either is1 or is2 is sufficient for Golgi localization in the sequence context of the gp41 cytoplasmic domain. (a) Schematic diagram of
the chimeric constructs with the CD4 extracellular/transmembrane and gp41 cytoplasmic domains used to identify the retention elements. (b) HeLa
cells were microinjected with the constructs indicated in panel a, stained with the CD4-specific monoclonal antibody Q4120 and a FITC-conjugated
secondary antibody, and subsequently analyzed by confocal laser scanning microscopy. The cross-section levels are indicated by white bars. The
cells shown are representative of all cells microinjected with the respective constructs. Similar results were obtained in at least three independent
experiments.
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for a further 30 min. DNA was blotted overnight by capillary transfer onto a
polyvinylidene difluoride nylon membrane using 203 SSC buffer (3 M NaCl, 300
mM sodium citrate [pH 7.0]). The DNA was subsequently fixed to the membrane
by UV cross-linking. Prehybridization was performed in hybridization buffer (53
SSC, 1% blocking reagent, 0.1% N-lauryl sarcosine, 0.02% sodium dodecyl
sulfate [SDS]) at 68°C for 1 h, followed by hybridization with the digoxigenin-
labeled probe in hybridization buffer at 68°C overnight. After two washes with
wash solution I (23 SSC, 0.1% SDS) at room temperature for 5 min and wash
solution II (0.13 SSC, 0.1% SDS) at 68°C for 15 min, the membrane was
equilibrated in Tris-buffered saline (TBS) buffer (10 mM Tris-HCl [pH 8], 150
mM NaCl). Subsequently the membrane was blocked with 5% milk powder–TBS
for 1 h, incubated with a peroxidase-conjugated anti-digoxigenin antibody
(Roche, Mannheim, Germany) for 1 h, and washed with TBST (10 mM Tris-HCl
[pH 8], 150 mM NaCl, 0.05% Tween 20). For chemiluminescence substrate
detection, the ECL Western blot detection reagents (Amersham Pharmacia
Biotech, Uppsala, Sweden) were used.
Microinjection and immunofluorescence. HeLa cells grown on glass coverslips
were microinjected with 0.05 mg of plasmid DNA/ml with an injection time of
0.5 s and a pressure of 60 hPa using the Eppendorf 5242/5170 microinjector
system (Eppendorf, Hamburg, Germany). After further growth overnight, cells
were washed with PBS and fixed with 3% paraformaldehyde–PBS for 20 min
followed by incubation with 50 mM NH4Cl–20 mM glycine–PBS for 10 min. Cells
were permeabilized with 0.2% Triton X-100–PBS for 10 min. Subsequently, cells
were blocked with 0.2% gelatin–PBS for 10 min and incubated with the primary
antibody for 30 min in the same buffer. HIV-1 Env was detected using the human
polyclonal antiserum 95-1, human CD4 by mouse antibody Q4120 (Sigma, St.
Louis, Mo.). After being washed three times with PBS, cells were incubated with
the secondary, fluorescein isothiocyanate (FITC)-conjugated antibodies (Di-
anova, Hamburg, Germany) for a further 30 min. After three final washes, the
coverslips were mounted on glass slides and viewed with a Leica TCS NT
confocal laser scanning microscope (Leica, Bensheim, Germany).
Flow cytometry. For immunofluorescence analysis, transfected cells were de-
tached from culture dishes by treatment with 1 mM EDTA–PBS. Cells were
washed with FACS buffer (PBS–0.5% fetal calf serum–0.03% NaN3) and incu-
bated for 30 min at 4°C with the human antiserum 95-1 at a dilution of 1:50.
Subsequently, cells were washed again and incubated for 30 min at 4°C with a
secondary anti-human IgG FITC-conjugated antibody at a dilution of 1:100.
Finally, cells were washed, resuspended in FACS buffer, and analyzed using a
FACSCalibur flow cytometer (Becton Dickinson, San Jose, Calif.).
RESULTS
Identification of two sequence elements in the gp41 cyto-
plasmic domain responsible for suppressed surface expres-
sion. The analysis of post-ER events regulating Env surface
expression is difficult, since the majority of the glycoprotein is
retained in the ER due to incorrect processing and interferes
with subsequent events (see Fig. 4). We thus decided to gen-
erate chimeric constructs using a CD4 extracellular/transmem-
brane domain and the gp41 cytoplasmic domain (56). Surface
expression was tested by immunofluorescence analysis of mi-
FIG. 5. The is1- and is2-induced Golgi localization is not influenced by HIV-1 Gag. HeLa cells were microinjected with either CD4Dcyt,
CD4gp41cyt, or CD4gp41Dis112 alone or in combination with HIV-1 gag at a DNA ratio of 1:1. Subsequently, cells were stained with the
CD4-specific monoclonal antibody Q4120 and a FITC-conjugated secondary antibody and analyzed by confocal laser scanning microscopy. To
control expression of the HIV-1 gag plasmid, HeLa cells microinjected with HIV-1 gag were stained with monoclonal antibody EH12E1 against
Gag.
FIG. 4. is1 and is2 are responsible for Golgi localization. (a) The cytoplasmic gp41 domain induces Golgi localization. HeLa cells microinjected
with either gp160, CD4Dcyt, CD4gp41cyt, or CD4gp41Dis112 were costained with antibodies against gp160 or CD4 (green fluorescence) and
either the ER marker calnexin or the Golgi marker mannosidase II (red fluorescence). (b) Chimeric CD4 fusion constructs exit the ER. 293 cells
transfected with either gp160, CD4Dcyt, CD4gp41cyt, or CD4gp41Dis112 were pulsed with [35S]Cys-[35S]Met for 1 h and subsequently chased as
indicated for 0, 6, or 10 h. Cell lysates were precipitated, digested with endoglycosidase H (Endo H), and subjected to electrophoresis on a 10%
polyacrylamide gel.
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croinjected HeLa cells using confocal laser scanning micros-
copy (Fig. 1). This approach was chosen since microinjection of
single cells with defined amounts of plasmid DNA proved to
be more reliable than analysis of bulk-transfected cultures.
As anticipated, addition of the gp41 cytoplasmic domain
drastically reduced surface expression of the chimeric mol-
ecule, which was even better illustrated if the immunofluo-
rescence staining of microinjected cells was analyzed by
cross-section (Fig. 1b). Intriguingly, the constructs with car-
boxy-terminal deletions between aa 856 (CD4gp41cyt) and 763
(CD4gp41D763) were localized in the Golgi compartment, but
the shorter deletion mutants, CD4gp41D749, CD4gp41D738,
CD4gp41D728, and CD4Dcyt, all showed significant surface
expression (Fig. 1). Thus, the sequence motif between aa 749
and 763 appears to be responsible for predominant Golgi lo-
calization. To analyze whether this element, termed is1 (inhib-
FIG. 6. Either is1 or is2 is sufficient for Golgi localization in a second heterologous system using an immunoglobulin extracellular domain. (a)
Schematic diagram of the chimeric constructs with the immunoglobulin (IG) extracellular domain, CD7 transmembrane stock, and gp41
cytoplasmic domain used to identify the retention elements. (b) HeLa cells were microinjected with the constructs indicated in panel a, stained with
a FITC-conjugated antibody against human immunoglobulin G, and subsequently analyzed by confocal laser scanning microscopy. The cross-
section levels are indicated by white bars. The cells shown are representative of all cells microinjected with the respective constructs. Similar results
were obtained in at least three independent experiments.
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itory sequence), is sufficient to prevent surface expression, we
cloned it directly 39 to the transmembrane region (Fig. 2). The
chimeric molecule CD4gp41:749–763 was expressed at the cell
surface, indicating that is1 is not sufficient for Golgi localiza-
tion if not expressed in the correct sequence context. However,
if the complete region between aa 749 and the carboxy-termi-
nal end was expressed 39 to the transmembrane region
(CD4gp41:749–856), surface expression was inhibited. Car-
boxy-terminal deletions of this construct identified a second
element, is2, which, in combination with is1, appeared to be
sufficient for Golgi localization without further sequence con-
text and the correct distance from the plasma membrane (Fig.
2). Subsequently, is1 and is2, separately or together, were de-
leted in the context of the complete gp41 cytoplasmic domain
(Fig. 3). Either of the two elements alone was able to inhibit
surface expression, and the chimeric protein was detected on
the plasma membrane only if both elements is1 and is2 to-
gether were deleted. To test whether the two dileucine motifs
FIG. 7. The nucleocytoplasmic mRNA export of a synthetic gp160 sequence is not inhibited. (a) Generation of a synthetic Env sequence
(scheme). The synthetic gp160 sequence (syngp160) was generated by 15 long oligonucleotides which were PCR-amplified using primers with the
indicated restriction sites. Amplification products were sequentially cloned into plasmids containing adapted multicloning sites and subcloned into
a pCDM7-derived expression plasmid. sp, signal peptide; v1 to v5, variable regions; fp, fusion peptide; tm, transmembrane region;1, cleavage site.
(b) RT-PCR analysis of nuclear and cytoplasmic RNA isolated from 293T cells transiently transfected with wild-type gp160. RNA was isolated by
CsC1 gradient isolation to avoid contamination with plasmid DNA and, after DNase treatment, transcribed into cDNA using an oligo(dT) primer.
Subsequently, the cDNA was used as a PCR template with either gp160 or actin primers. PCR products were separated on an agarose gel, blotted
onto a polyvinylidene difluoride membrane, and subsequently hybridized with a gp160-specific probe. Quantitative analysis was performed using
Image Master ID Elite software (Amersham Pharmacia Biotech). (c) RT-PCR analysis of nuclear and cytoplasmic RNA isolated from 293T cells
transiently transfected with syngp160.
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present in is2 are responsible for suppressed surface expression
and Golgi retention or retrieval, we mutated either of the two
separately or both of them together (Fig. 3). However, there
was no surface expression with either of these chimeric con-
structs, similar to the construct in which the is2 region has been
deleted.
To test that the identified sequence motifs is1 and is2 in fact
cause Golgi localization, we performed colocalization experi-
ments with ER and Golgi marker proteins. Whereas HIV-1
gp160 colocalized predominantly with the ER marker calnexin,
the chimeric CD4gp41cyt fusion protein was detected mainly
in the Golgi and was thus found to costain with mannosidase II
(Fig. 4a). In contrast to CD4gp41cyt, a considerable portion of
CD4Dcyt and CD4gp41Dis112 was detected at the cell surface,
and only a minor amount of the protein colocalized with man-
nosidase II. To confirm biochemically that the chimeric CD4
fusion proteins had left the ER and were not subjected to ER
retention and degradation due to incorrect folding, we per-
formed Endo H digests of lysates from cells transfected with
the key mutants in pulse-chase experiments. In accordance
FIG. 8. Deletion of is1 and is2 restores surface expression of Env. (a) Schematic diagram of the syngp160 constructs used to evaluate surface
expression. (b) The cytoplasmic domain of gp41 is responsible for suppressed surface expression. HeLa cells were stably transfected with syngp160
and syngp160Dcyt using a bovine papillomavirus-based, replicating vector. Nonpermeabilized bulk cultures were stained with the Env-specific
human antiserum 95-1 and a FITC-conjugated secondary antibody and subsequently analyzed by flow cytometry. As a negative control (dashed
line), cells were treated only with the secondary antibody. (c) Quantitative analysis of Env surface expression. 293T cells transiently transfected with
either syngp160, syngp160Dcyt, or syngp160Dis112 were stained with the Env-specific human antiserum 95-1 and a FITC-conjugated secondary
antibody without prior permeabilization and subsequently analyzed by flow cytometry. Surface expression (mean 6 standard error of the mean of
seven independent experiments) was calculated by subtracting the mean of the negative control from the mean of the cells stained with both the
primary and the secondary antibody. (d) Western blot analysis of 293T cells transiently transfected with either syngp160, syngp160Dcyt, or
syngp160Dis112. Cells from one experiment were split into two groups and used for either immunofluorescence or Western blotting. The Western
blot was reacted with the Env-specific human antiserum 95-1.
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with the colocalization experiments, we found that CD4Dcyt,
CD4gp41cyt, and CD4gp41Dis112 were completely Endo H
resistant after a 6-h chase, indicating that all these fusion
proteins had reached the medial Golgi and that the cytoplas-
mic gp41 domain thus did not influence the ER exit (Fig. 4b).
In contrast, the gp160 glycoprotein was still almost completely
Endo H sensitive after both 6 and 10 h of chase, indicating that
it was retained within the ER.
Subsequently, we tested whether the gp41 cytoplasmic do-
main-induced Golgi localization would be influenced by HIV-1
Gag. A plasmid carrying gag was coinjected into HeLa cells at
a DNA ratio of 1:1 (Fig. 5). Since the DNA was coinjected
rather than cotransfected, all cells expressing the chimeric CD4
proteins also expressed HIV-1 Gag. Correct expression of the
HIV-1 gag construct used was tested by staining with an anti-
Gag monoclonal antibody. HIV-1 Gag had no effect on the
localization of either of the chimeric CD4 proteins, and
CD4gp41cyt was found in the Golgi independent of HIV-1
Gag expression.
To control that this effect was not artifically caused by the
CD4 extracellular/transmembrane region, we generated a sec-
ond set of chimeric constructs using surface-anchored IgG1 in
combination with the gp41 cytoplasmic domain (Fig. 6). Sim-
ilarly to the CD4 chimeras, surface expression was consider-
ably reduced if the gp41 cytoplasmic domain was added 39 to
the transmembrane region and could be restored by deletion of
both is1 and is2. Moreover, surface expression was suppressed
if both elements were added directly 39 to the immunoglobulin
transmembrane region. In conclusion, in both heterologous
systems the elements is1 and is2 behaved similarly and induced
localization to the Golgi. Either of the two elements is suffi-
cient to inhibit surface expression if deleted separately, and
only deletion of both of them restores surface expression.
is1 and is2 inhibit surface expression of gp160. In contrast to
most cellular transcripts, the majority of HIV-1 Env mRNA is
retained in the nucleus (Fig. 7b). RT-PCR analysis of nuclear
and cytosolic mRNA isolated from 293T cells expressing
HIV-1 gp160 indicated that only 18% of the viral mRNA can
be found in the cytosol, whereas more than 80% was retained
in the nucleus. In contrast to the case with gp160, approxi-
mately 50% of the cellular actin mRNA was detected in the
cytosol. Thus, we confirmed previous data indicating that
gp160 contains inhibitory sequence motifs retaining the viral
mRNA in the nucleus (2, 7, 12, 21, 45, 56, 60, 61). To identify
peptide motif(s) responsible for inhibition of protein export,
we thus had to choose strategies which eliminated the inter-
fering mRNA retention.
To test whether the identified sequence elements are also
responsible for inhibited surface expression in the homologous
context, we decided to generate a synthetic gp160 gene in
which the primary sequence codons have been replaced by
synonymous codons. In the HIV-1 env gene, codons with either
adenine or thymine at the third codon position are preferen-
tially used (11; P. Grantham and P. Perrin, Letter, Nature
319:727–728, 1986). We substituted codons with guanine or
cytosine for most codons with adenine or thymine at the third
position. The synthetic gp160 sequence (syngp160) was gener-
ated by long 150- to 200-mer oligonucleotides, which were
amplified by PCR and sequentially cloned into two plasmids
containing suitable polylinkers. Finally, the two sequences cod-
ing for gp120 and gp41 were subcloned into a pCDM7-based
expression plasmid containing the immediate-early promoter
of human cytomegalovirus and tested by Western blot analysis
of cell lysates from transiently transfected cells for the correct
length (Fig. 7a). RT-PCR analysis of nuclear and cytoplasmic
mRNA indicated that in contrast to the wild-type env se-
quence, the syngp160 mRNA is not retained in the nucleus
(Fig. 7c). More than 40% of the syngp160 mRNA was found in
the cytoplasmic fraction, similarly to actin mRNA (48% in the
cytoplasmic fraction). Since we were unable to detect intron-
containing transcripts in the cytoplasmic fractions by RT-PCR
using primers annealing in the intron (the vector used contains
a small intron in the 39 untranslated region), we conclude that
the cytosolic fractions were properly isolated and not contam-
inated by nuclear RNA (data not shown).
Deletion of the gp41 cytoplasmic domain considerably in-
creased surface expression in 293T cells stably or transiently
transfected (Fig. 8). Quantitative flow-cytometric analysis of
293T cells transiently transfected with either syngp160 or
syngp160Dcyt indicated that surface expression was reduced to
less than 20% by the cytoplasmic domain (Fig. 8c). In contrast,
the total cellular glycoprotein amount was similar in the West-
ern blot analysis, indicating that reduced surface expression
was not due to decreased production rates (Fig. 8d). Similarly
to the results in the two heterologous systems, elimination of
both is1 and is2 (syngp160Dis112) resulted in an almost four-
fold increase of surface expression compared to syngp160 con-
taining the complete cytoplasmic domain, suggesting that the
two elements is1 and is2 act similarly in the context of homol-
ogous Env.
DISCUSSION
In this study, we were able to identify sequence elements in
the cytoplasmic tail of the HIV-1 Env glycoprotein which in-
hibit cell surface expression. To investigate post-ER events
without interference of ER-retained, misfolded glycoprotein,
we used two heterologous systems. We found that two ele-
ments, is1 and is2, inhibit surface expression and induce local-
ization to the Golgi. Generally, Golgi localization can be
caused by either retrieval or retention signals. Retention sig-
nals of resident Golgi transmembrane proteins are located
mainly in the transmembrane domain (44, 46). Two models
have been proposed for transmembrane Golgi retention mo-
tifs: the first is based on retention through oligomerization to
large aggregates, and the second postulates retention through
a different length of membrane-spanning domains regarding
the differences in membrane thickness along the exocytic path-
way. Retrieval signals have been found in several trans-Golgi
proteins that recycle between the plasma membrane and the
Golgi complex and are composed of either tyrosine-based or
dileucine motifs (8, 51, 59).
The gp41 cytoplasmic domain is a strong inducer of endo-
cytosis, and is1 and is2 appear to act predominantly as retrieval
motifs (data not shown). In time course analyses, approxi-
mately 40% of a chimeric CD4 molecule with the cytoplasmic
gp41 domain was endocytosed after 15 min, and 60% was
endocytosed after 60 min (data not shown). In contrast, only
approximately 5% of the CD4 control molecule without the
cytoplasmic gp41 domain was internalized after 15 min, and
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10% after 60 min. Similar results were presented in a recent
study with recombinant vaccinia virus expressing gp160 with or
without the cytoplasmic domain (58). In this study, it was found
that .50% of the gp160 was internalized after 60 min, but only
approximately 15% was internalized if the cytoplasmic domain
was absent. A membrane-proximal, tyrosine-based YXXF mo-
tif (aa 713 to 716) was recently found to mediate endocytosis of
gp160 (4, 58). This motif appears to be bound by clathrin-
associated m1 and m2 subunits of AP adaptor complexes, and
its function is suppressed in the presence of the HIV-1 Gag
precursor polyprotein (4, 19). However, both groups report
that additional determinants distal to the YXXF motif may be
involved (4, 58). Intriguingly, we observed only little or no
effect of the gp160 amino acids 707 to 749 including the YXXF
motif (Fig. 1) (CD4D749, CD4D738, and CD4D728) on steady-
state surface expression (in comparison to results with
CD4Dcyt) in this study. We conclude that in terms of steady-
state surface expression, the two membrane-distal elements is1
and is2 determined in this study are even more important than
the proximal tyrosine-based YXXF motif.
The gp41 cytoplasmic domain (148 aa) contains several
dileucine motifs known to mediate Golgi retrieval in a variety
of other molecules (1). The dileucine motifs present in is2
appear to be rather conserved between different isolates (Fig.
9). The aa 784/5 dileucine motif was found to be completely
conserved between all consensus subtype A to D sequences,
and in the aa 776/7 dileucine motif the first leucine was found
to be replaced by an isoleucine in the subtype A, C, and D
consensus sequences. Previous reports have shown that isoleu-
cine-leucine motifs act similarly as a dileucine motif in Golgi
retrieval (47). In this study, the two dileucine motifs present in
is2 were not sufficient to inhibit surface expression and needed
additional sequence context to inhibit surface expression.
Intriguingly, the inhibitory element is1 does not contain any
known retrieval or retention signal. Beyond its rather hydro-
phobic structure and three leucine residues in an equal dis-
tance of seven amino acids, there are no other apparent fea-
tures of this motif. The inhibitory element is2 is nearly identical
to the previously identified lentivirus lytic peptide LLP2 (aa
768 to 788), which was described (together with the lentivirus
lytic peptide LLP1 (aa 828 to 855) as an amphipathic structure
that associates with membranes and was reported to alter
membrane permeability by channel formation (20, 40, 41, 65,
68). Furthermore, LLPs possess calmodulin-binding capacity,
modulate intracellular signaling, and contribute to the cyto-
pathogenic effect of Env (3, 34, 41).
In HIV-1 and other retroviruses, glycoprotein surface ex-
pression is strictly regulated. Willey and colleagues reported
that in HIV-1-infected peripheral blood mononuclear cells,
less than 15% of the total gp160 amount is cleaved to gp120
within 24 h, indicating that the majority of the protein is not
transported to the plasma membrane (69). In this study, we
show that the cytoplasmic domain is responsible for restricted
expression, which is in accordance with previous reports indi-
cating its involvement in intracellular trafficking, surface ex-
pression, and incorporation into virus particles (52, 55, 70).
There are several lines of evidence suggesting that restricted
surface expression of glycoproteins is crucial for the virus in
vivo. Whereas in vitro culture of SIV and HIV-2 selects for TM
truncations, revertants which express full-length Env again can
be detected after administration of SIV mutants with truncated
cytoplasmic TM domains into rhesus macaques (37). Second,
the virus has obviously developed several independent strate-
gies on different levels to suppress glycoprotein expression:
inhibition of mRNA transport and glycoprotein Golgi reten-
tion or retrieval, both of which appear to be highly coordinated
(19, 21, 23, 38). Stressing their importance, both strategies
appear to be conserved in all HIV-1 viruses independently of
subtype or isolate, despite the high mutation rate. In accor-
dance with this observation, the main features of the two ele-
ments, is1 and is2, presented in this report appear to be con-
served between different isolates (Fig. 9). Currently, we have
no hints for an alternative function of Golgi retention or re-
trieval of the Env glycoprotein. The elimination of the YXXF
motif, for example, had no effect on major histocompatibility
complex class II-restricted presentation of Env-derived pep-
tides (58).
The transcripts of the synthetic sequence with synonymous
codons generated in this study were not retained within the
nucleus, indicating that the approach to eliminating inherent,
poorly localized negative elements by synonymous codons
might represent a novel strategy to increase viral glycoprotein
expression (Fig. 7). Due to a direct interaction between Env
and viral matrix proteins, the carboxy-terminal end of the gp41
FIG. 9. is1 and is2 are conserved between different HIV-1 isolates.
The gp41 cytoplasmic domain (aa 707 to 856) of the HIV-1 MN isolate
and the consensus sequences of subtype A, B, C, and D isolates
(according to the Los Alamos National Library Database) were com-
pared using standard software of the University of Wisconsin Genetics
Computer Group (CLUSTAL program). The Golgi retention or re-
trieval motifs is1 and is2 are marked below the sequence, and identical
amino acids are indicated by grey boxes.
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cytoplasmic domain appears to influence the incorporation of
glycoproteins into virions (13, 15, 16, 22, 25, 28, 39, 72, 73).
Thus, the gp160 mutant with the short internal deletion of is1
and is2, syngp160Dis1–2, which is considerably more highly
expressed at the cell surface in comparison to wild-type Env,
should still be incorporated into virus particles. In conse-
quence, this construct might prove to be useful for further
studies on HIV-1 Env-pseudotyped viruses and for gene ther-
apeutical applications, since elements necessary for virion in-
corporation are still present.
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